Evrysdi & Tagrisso Among Myriad Products To Win English Funding

 
• By Neena Brizmohun

Roche’s oral treatment for spinal muscular atrophy and AstraZeneca’s non-small-cell lung cancer drug are among a number of medicines to get the thumbs up from the health technology assessment body, NICE.

A number of new drugs are being made available via NHS England • Source: Alamy

More from United Kingdom

More from Europe